Cargando…

Inhaled Corticosteroids and COVID-19

Detalles Bibliográficos
Autores principales:	Lipworth, Brian, Kuo, Chris RuiWen, Lipworth, Samuel, Chan, Rory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491401/ https://www.ncbi.nlm.nih.gov/pubmed/32668178 http://dx.doi.org/10.1164/rccm.202005-2000LE

Ejemplares similares

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on
por: Lipworth, Brian, et al.
Publicado: (2020)

COVID-19: Start with the nose
por: Lipworth, Brian, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Sex Hormones and Asthma: Don’t Forget Progesterone
por: Lipworth, Brian, et al.
Publicado: (2020)

Resistance Heterogeneity and Small Airway Asthma Phenotype
por: Lipworth, Brian, et al.
Publicado: (2019)

Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection
por: Lipworth, Brian, et al.
Publicado: (2020)

Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword
por: Lipworth, Brian, et al.
Publicado: (2021)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

Systemic IL-6 and Severe Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Does unified allergic airway disease impact on lung function and type 2 biomarkers?
por: Kuo, Chris RuiWen, et al.
Publicado: (2019)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

Corticosteroid Protection Against COVID-19: Begin with the Nose
por: Lipworth, Brian J., et al.
Publicado: (2021)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Predicting Severe Outcomes in COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

I Say IOS You Say AOS: Comparative Bias in Respiratory Impedance Measurements
por: Kuo, Chris RuiWen, et al.
Publicado: (2019)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Normal spirometry equates to normal impulse oscillometry in healthy subjects
por: Lipworth, Brian, et al.
Publicado: (2021)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab
por: Chan, Rory, et al.
Publicado: (2023)

COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study
por: Chan, Rory, et al.
Publicado: (2022)

Impact of Biologic Therapy on the Small Airways Asthma Phenotype
por: Chan, Rory, et al.
Publicado: (2022)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
por: Chan, Rory, et al.
Publicado: (2023)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Phenotypic associations of medical polypectomy and revision surgery following endoscopic sinus surgery: a retrospective study of a single-centre experience in Scotland
por: Misirovs, Rasads, et al.
Publicado: (2023)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

Beyond Duty: Medical “Heroes” and the COVID-19 Pandemic
por: Lipworth, Wendy
Publicado: (2020)

Safety and efficacy of the Russian COVID-19 vaccine: more information needed
por: Bucci, Enrico, et al.
Publicado: (2020)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Han, MeiLan K., et al.
Publicado: (2021)

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease
por: Taboada, Manuel, et al.
Publicado: (2020)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_54orolukugbii9pb9omrua87tl